1,386
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Hyperoside exerts osteoprotective effect on dexamethasone-induced osteoblasts by targeting NADPH Oxidase 4 (NOX4) to inhibit the reactive oxygen species (ROS) accumulation and activate c-Jun N-terminal kinase (JNK) pathway

, , , &
Pages 8657-8666 | Received 30 Dec 2021, Accepted 11 Mar 2022, Published online: 24 Mar 2022

References

  • Wu X, Sun W, Tan M. Noncoding RNAs in Steroid-Induced Osteonecrosis of the Femoral Head. Biomed Res Int. 2019;2019:8140595.
  • Wang A, Ren M, Wang J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: a systematic review of the literature. Gene. 2018;671:103–109.
  • Chang C, Greenspan A, Gershwin ME. The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 2020;110:102460.
  • Zhan J, Yan Z, Zhao M, et al. Allicin inhibits osteoblast apoptosis and steroid-induced necrosis of femoral head progression by activating the PI3K/AKT pathway. Food Funct. 2020;11(9):7830–7841.
  • Wei A, Song Y, Ni T, et al. Hyperoside attenuates pregnancy loss through activating autophagy and suppressing inflammation in a rat model. Life Sci. 2020;254:117735.
  • Qiu J, Zhang T, Zhu X, et al. Hyperoside Induces Breast Cancer Cells Apoptosis via ROS-Mediated NF-κB Signaling Pathway. Int J Mol Sci. 2019;21(1):131.
  • Huang J, Tong X, Zhang L, et al. Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice. Front Pharmacol. 2020;11:550955.
  • Zhang N, Ying MD, Wu YP, et al. Hyperoside, a flavonoid compound, inhibits proliferation and stimulates osteogenic differentiation of human osteosarcoma cells. PloS one. 2014;9(7):e98973.
  • Chen Y, Dai F, He Y, et al. Beneficial effects of hyperoside on bone metabolism in ovariectomized mice. Biomed Pharmacothe. 2018;107:1175–1182.
  • Xu T, Wu X, Zhou Z, et al. Hyperoside ameliorates periodontitis in rats by promoting osteogenic differentiation of BMSCs via activation of the NF-κB pathway. FEBS Open Bio. 2020;10(9):1843–1855.
  • Yan Z, Zhan J, Qi W, et al. The Protective Effect of Luteolin in Glucocorticoid-Induced Osteonecrosis of the Femoral Head. Front Pharmacol. 2020;11:1195.
  • Kuang MJ, Zhang WH, He WW, et al. Naringin regulates bone metabolism in glucocorticoid-induced osteonecrosis of the femoral head via the Akt/Bad signal cascades. Chem Biol Interact. 2019;304:97–105.
  • Wang XY, Gong LJ, Huang JM, et al. Pinocembrin alleviates glucocorticoid-induced apoptosis by activating autophagy via suppressing the PI3K/Akt/mTOR pathway in osteocytes. Eur J Pharmacol. 2020;880:173212.
  • Peng P, Nie Z, Sun F, et al. Glucocorticoids induce femoral head necrosis in rats through the ROS/JNK/c-Jun pathway. FEBS Open Bio. 2021;11(1):312–321.
  • Fan ZQ, Bai SC, Xu Q, et al. Oxidative Stress Induced Osteocyte Apoptosis in Steroid-Induced Femoral Head Necrosis. Orthop Surg. 2021;13(7):2145–2152.
  • Farnsworth NR, Wagner H, Hörhammer L, et al. Aster pilosus (Compositae). I. Isolation of hyperoside (quercetin-3-beta-D-mono-galactoside) from the leaves. J Pharm Sci. 1968;57(6):1059–1061.
  • Li S, Zhang Z, Cain A, et al. Antifungal activity of camptothecin, trifolin, and hyperoside isolated from Camptotheca acuminata. J Agric Food Chem. 2005;53(1):32–37.
  • Wong RW, Rabie AB. Traditional Chinese medicines and bone formation–a review. J Oral Maxillofacial Surg. 2006;64(5):828–837.
  • Che CT, Wong MS, Lam CW. Natural Products from Chinese Medicines with Potential Benefits to Bone Health. Molecules (Basel Switzerland). 2016;21( 3):239.
  • Jang HO, Park YS, Lee JH, et al. Effect of extracts from safflower seeds on osteoblast differentiation and intracellular calcium ion concentration in MC3T3-E1 cells. Nat Prod Res. 2007;21(9):787–797.
  • Choi EM. Deoxyactein stimulates osteoblast function and inhibits bone-resorbing mediators in MC3T3-E1 cells. J Appl Toxicol. 2013;33(3):190–195.
  • Kim J, Lee H, Kang KS, et al. Cordyceps militaris mushroom and cordycepin inhibit RANKL-induced osteoclast differentiation. J Med Food. 2015;18(4):446–452.
  • Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014;22(7):455–464.
  • Boyce BF, Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473(2):139–146.
  • Huang C, Gan D, Luo F, et al. Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways as New Anti- fibrosis Targets of Ursolic Acid in Hepatic Stellate Cells. Front Pharmacol. 2019;10:431.
  • Deng S, Zhou JL, Fang HS, et al. Sesamin Protects the Femoral Head From Osteonecrosis by Inhibiting ROS-Induced Osteoblast Apoptosis in Rat Model. Front Physiol. 2018;9:1787.
  • Liu Z, Tao X, Zhang C, et al. Protective effects of hyperoside (quercetin-3-o-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide. Biomed Pharmacothe. 2005;59(9):481–490.
  • Suzuki M, Bandoski C, Bartlett JD. Fluoride induces oxidative damage and SIRT1/autophagy through ROS-mediated JNK signaling. Free Radic Biol Med. 2015;89:369–378.